Intellectual Property India Publishes Patent Application for 'Anti-Egfr/Met Antibodies And Uses Thereof' Filed by Doma Biopharmaceutical (SUZHOU) Co. Ltd.

MUMBAI, India, Jan. 31 -- Intellectual Property India has published a patent application (202427097939 A) filed by Doma Biopharmaceutical (SUZHOU) Co. Ltd., Jiangsu, China, on Dec. 11, 2024, for 'anti-egfr/met antibodies and uses thereof.'

Inventor(s) include Han, Yanfei; Shang, Chengzhang; Liu, Baihong; Yang, Yi; and Shen, Yuelei.

The application for the patent was published on Jan. 31, under issue no. 05/2025.

According to the abstract released by the Intellectual Property India: "Provided are antigen-binding protein constructs (e.g., bispecific antibodies, antigen-binding fragments thereof, or ADCs), wherein the antigen-binding protein constructs specifically bind to two different antigens (e.g., EGFR and MET)."

The patent applicatio...